Delivery Order SPE2DB24D1201-SPE2DB25FJCCC
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,927.20 firm-fixed-price contract is for the delivery of 4,565,638,359 units of the prescription drug VYVANSE 30 MG CAPSULE 100S. The order has an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for...
This federal contract award, valued at $2,712.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product, with a period of performance ending on March 31, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,992.51 firm fixed-price delivery order is for 4,566,929,622 units of the prescription drug VYVANSE 20 mg capsules. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,819.10 firm fixed-price contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a specialty pharmaceutical product. The contract has a completion date of January 23, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $1,052.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 30 MG CAPSULES 100S, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 10, 2024. The contract was awarded on December 9, 2024 and was not designated with a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,872.89, is a delivery order for 4567584948 VYVANSE 30 MG CAPSULE 100S. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. The contract is a Firm Fixed Price agreement and does not have a set-aside designation, indicating open competition....
This is a $4,465.82 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,242,894 units of the pharmaceutical product VYVANSE 20 MG CAPSULE 100S. The award has a completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an award value of $2,958.88, is for the delivery of VYVANSE 10 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 6, 2025. This award is not associated with a set-aside program. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,378.53, is for the delivery of 4567745587 VYVANSE 30 MG CAPSULE 100S. The contract is a Delivery Order under a Firm Fixed Price structure, with an ultimate completion date of April 1, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,739.46 firm fixed-price delivery order is for the supply of 4,567,037,806 units of the 20 mg VYVANSE capsule. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 24, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...